LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 74

Search options

  1. Article: [Control of bone remodeling by nervous system. Regulation of bone metabolism by peripheral nervous system].

    Togari, Akifumi

    Clinical calcium

    2010  Volume 20, Issue 12, Page(s) 1831–1838

    Abstract: Bone is richly innervated with adrenergic and peptidergic nerve terminals, and these play important roles in bone remodeling. Recent study confirmed a functional nerve-osteoblastic interplay by using an in vitro co-culture model comprising mouse ... ...

    Abstract Bone is richly innervated with adrenergic and peptidergic nerve terminals, and these play important roles in bone remodeling. Recent study confirmed a functional nerve-osteoblastic interplay by using an in vitro co-culture model comprising mouse osteoblastic cells and neurite-spouting mouse superior cervical ganglia. This indicates that nerve-osteoblastic cell cross-talk can occur for the dynamic regulation of local bone metabolism by peripheral nervous system. This review summarized both in vivo and in vitro evidences implicating peripheral neuron action in bone metabolism.
    MeSH term(s) Animals ; Bone Remodeling/physiology ; Bone and Bones/innervation ; Bone and Bones/metabolism ; Humans ; Mice ; Neurites/physiology ; Neurons/physiology ; Neurotransmitter Agents/physiology ; Norepinephrine/physiology ; Osteoblasts/physiology ; Osteoclasts/physiology ; Peripheral Nervous System/physiology ; Receptors, Adrenergic, beta-2/physiology ; Superior Cervical Ganglion/physiology ; Synapses
    Chemical Substances Neurotransmitter Agents ; Receptors, Adrenergic, beta-2 ; Norepinephrine (X4W3ENH1CV)
    Language Japanese
    Publishing date 2010-12
    Publishing country Japan
    Document type English Abstract ; Journal Article ; Review
    ZDB-ID 2386417-5
    ISSN 0917-5857
    ISSN 0917-5857
    DOI CliCa101218311838
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Systemic administration of low-dose naltrexone increases bone mass due to blockade of opioid growth factor receptor signaling in mice osteoblasts.

    Tanaka, Kenjiro / Kondo, Hisataka / Hamamura, Kazunori / Togari, Akifumi

    Life sciences

    2019  Volume 224, Page(s) 232–240

    Abstract: Aims: Opioid receptor blockers such as naloxone and naltrexone have been suggested to have a bone mass-increasing effect. However, the mechanisms at play have not been clarified. We examined the effects of naltrexone on osteoblasts and determined the ... ...

    Abstract Aims: Opioid receptor blockers such as naloxone and naltrexone have been suggested to have a bone mass-increasing effect. However, the mechanisms at play have not been clarified. We examined the effects of naltrexone on osteoblasts and determined the expression of opioid growth factor receptor (OGFR) in osteoblasts. Naltrexone blocks the OGFR and other canonical opioid receptors. Thus, we designed experiments to clarify the effects of naltrexone on bone tissue by examining the physiological role of OGFR signaling in osteoblasts and the changes in bone structure after naltrexone systemic administration in mice.
    Main methods: We used mouse osteoblast-like cell line MC3T3-E1 for in vitro experiments. We cultured MC3T3-E1 cells in the presence of the OGFR agonist met-enkephalin (met-enk). Then, we measured cell proliferation activity and analyzed the expression levels of cell proliferation-related genes. For our in vivo experiments, we administered naltrexone intraperitoneally to mice daily for 28 days and administered the animals in the control group equivalent volumes of saline. After sacrificing the mice, we performed micro-computed tomography and bone morphology analyses.
    Key findings: Met-enk suppressed cell proliferation in MC3T3-E1 cells. Moreover, Low dose naltrexone administration significantly increased their femoral bone mass, bone formation ratio, and osteoblast number/bone surface values when comparing the values for the same variables in the control group.
    Significance: Our results suggest that naltrexone increases bone mass due to osteoblast number increments caused by the OGFR signaling block. Opioid receptor blockers have potential as therapeutic agents for osteoporosis as well as opioid antagonists.
    MeSH term(s) Animals ; Bone Density/drug effects ; Cell Proliferation ; Cells, Cultured ; Enkephalin, Methionine/pharmacology ; Male ; Mice ; Mice, Inbred ICR ; Naltrexone/administration & dosage ; Naltrexone/pharmacology ; Narcotic Antagonists/administration & dosage ; Narcotic Antagonists/pharmacology ; Neurotransmitter Agents/pharmacology ; Osteoblasts/cytology ; Osteoblasts/drug effects ; Osteoblasts/metabolism ; Receptors, Opioid/chemistry ; Receptors, Opioid/genetics ; Receptors, Opioid/metabolism
    Chemical Substances Narcotic Antagonists ; Neurotransmitter Agents ; Receptors, Opioid ; methionine-enkephalin receptor ; Enkephalin, Methionine (58569-55-4) ; Naltrexone (5S6W795CQM)
    Language English
    Publishing date 2019-03-28
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 3378-9
    ISSN 1879-0631 ; 0024-3205
    ISSN (online) 1879-0631
    ISSN 0024-3205
    DOI 10.1016/j.lfs.2019.03.069
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: [Increased bone resorption by sympathetic nervous activity].

    Togari, Akifumi

    Clinical calcium

    2006  Volume 16, Issue 2, Page(s) 298–303

    Abstract: Recent experimental studies showed the dynamic neural regulation of local bone metabolism. Increased sympathetic nervous activity has been demonstrated to cause bone loss via an increase in bone resorption and a decrease in bone formation. This review ... ...

    Abstract Recent experimental studies showed the dynamic neural regulation of local bone metabolism. Increased sympathetic nervous activity has been demonstrated to cause bone loss via an increase in bone resorption and a decrease in bone formation. This review summarized both in vivo and in vitro evidences implicating sympathetic neuron action in bone resorption.
    MeSH term(s) Animals ; Bone Resorption/physiopathology ; Osteoclasts/physiology ; Sympathetic Nervous System/physiology
    Language Japanese
    Publishing date 2006-02
    Publishing country Japan
    Document type English Abstract ; Journal Article ; Review
    ZDB-ID 2386417-5
    ISSN 0917-5857
    ISSN 0917-5857
    DOI CliCa0602298303
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Guanabenz inhibits alveolar bone resorption in a rat model of periodontitis.

    Muramatsu, Ryujiro / Sato, Takuma / Hamamura, Kazunori / Miyazawa, Ken / Takeguchi, Atsushi / Tabuchi, Masako / Togari, Akifumi / Goto, Shigemi

    Journal of pharmacological sciences

    2021  Volume 147, Issue 3, Page(s) 294–304

    Abstract: Increase of sympathetic activity has been known to exacerbate osteoporosis through promotion of bone resorption. However, it is largely unknown about involvement of sympathetic activity in exacerbation of periodontitis. In this study, we investigated ... ...

    Abstract Increase of sympathetic activity has been known to exacerbate osteoporosis through promotion of bone resorption. However, it is largely unknown about involvement of sympathetic activity in exacerbation of periodontitis. In this study, we investigated whether α
    MeSH term(s) Adrenergic alpha-2 Receptor Agonists/administration & dosage ; Adrenergic alpha-2 Receptor Agonists/pharmacology ; Animals ; Bone Resorption/etiology ; Bone Resorption/metabolism ; Bone Resorption/physiopathology ; Bone Resorption/prevention & control ; Cytokines/metabolism ; Disease Models, Animal ; Guanabenz/administration & dosage ; Guanabenz/pharmacology ; Inflammation Mediators/metabolism ; Male ; Periodontitis/complications ; Periodontitis/metabolism ; Periodontitis/physiopathology ; Periodontium/metabolism ; Rats, Inbred SHR ; Rats, Inbred WKY ; Sympathetic Nervous System/drug effects ; Sympathetic Nervous System/physiopathology ; Rats
    Chemical Substances Adrenergic alpha-2 Receptor Agonists ; Cytokines ; Inflammation Mediators ; Guanabenz (GGD30112WC)
    Language English
    Publishing date 2021-08-14
    Publishing country Japan
    Document type Journal Article
    ZDB-ID 2104264-0
    ISSN 1347-8648 ; 1347-8613
    ISSN (online) 1347-8648
    ISSN 1347-8613
    DOI 10.1016/j.jphs.2021.08.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Systemic administration of low-dose naltrexone increases bone mass due to blockade of opioid growth factor receptor signaling in mice osteoblasts

    Tanaka, Kenjiro / Hamamura, Kazunori / Kondo, Hisataka / Togari, Akifumi

    Life sciences. 2019 May 01, v. 224

    2019  

    Abstract: Opioid receptor blockers such as naloxone and naltrexone have been suggested to have a bone mass-increasing effect. However, the mechanisms at play have not been clarified. We examined the effects of naltrexone on osteoblasts and determined the ... ...

    Abstract Opioid receptor blockers such as naloxone and naltrexone have been suggested to have a bone mass-increasing effect. However, the mechanisms at play have not been clarified. We examined the effects of naltrexone on osteoblasts and determined the expression of opioid growth factor receptor (OGFR) in osteoblasts. Naltrexone blocks the OGFR and other canonical opioid receptors. Thus, we designed experiments to clarify the effects of naltrexone on bone tissue by examining the physiological role of OGFR signaling in osteoblasts and the changes in bone structure after naltrexone systemic administration in mice.We used mouse osteoblast-like cell line MC3T3-E1 for in vitro experiments. We cultured MC3T3-E1 cells in the presence of the OGFR agonist met-enkephalin (met-enk). Then, we measured cell proliferation activity and analyzed the expression levels of cell proliferation-related genes. For our in vivo experiments, we administered naltrexone intraperitoneally to mice daily for 28 days and administered the animals in the control group equivalent volumes of saline. After sacrificing the mice, we performed micro-computed tomography and bone morphology analyses.Met-enk suppressed cell proliferation in MC3T3-E1 cells. Moreover, Low dose naltrexone administration significantly increased their femoral bone mass, bone formation ratio, and osteoblast number/bone surface values when comparing the values for the same variables in the control group.Our results suggest that naltrexone increases bone mass due to osteoblast number increments caused by the OGFR signaling block. Opioid receptor blockers have potential as therapeutic agents for osteoporosis as well as opioid antagonists.
    Keywords agonists ; bone density ; bone formation ; cell lines ; cell proliferation ; femur ; genes ; in vitro studies ; in vivo studies ; mice ; micro-computed tomography ; naloxone ; narcotic antagonists ; osteoblasts ; osteoporosis ; receptors ; therapeutics
    Language English
    Dates of publication 2019-0501
    Size p. 232-240.
    Publishing place Elsevier Inc.
    Document type Article
    ZDB-ID 3378-9
    ISSN 1879-0631 ; 0024-3205
    ISSN (online) 1879-0631
    ISSN 0024-3205
    DOI 10.1016/j.lfs.2019.03.069
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article ; Online: Effects of a β2-adrenergic receptor blocker on experimental periodontitis in spontaneously hypertensive rats.

    Takeguchi, Atsushi / Miyazawa, Ken / Sato, Takuma / Tabuchi, Masako / Muramatsu, Ryujiro / Maeda, Hatsuhiko / Togari, Akifumi / Goto, Shigemi

    Life sciences

    2021  Volume 277, Page(s) 119593

    Abstract: Aims: Recent studies have reported a relationship between periodontal disease and hypertension, and previous evidence suggests that the sympathetic nervous system plays an important role in the control of bone metabolism. This study sought to evaluate ... ...

    Abstract Aims: Recent studies have reported a relationship between periodontal disease and hypertension, and previous evidence suggests that the sympathetic nervous system plays an important role in the control of bone metabolism. This study sought to evaluate the effect of the beta-2 adrenergic receptor (β2-AR) blocker butoxamine on experimental periodontitis in a rat model.
    Materials and methods: Wistar-Kyoto and spontaneously hypertensive rats (n = 6 per group) were orally administered butoxamine 1 mg/kg/day and experimental periodontitis was induced by applying an orthodontic ligature wire. The rats were sacrificed after 4 weeks and the residual alveolar bone was measured using micro-computed tomography (micro-CT) imaging analysis software for histological analysis.
    Key findings: Micro-CT imaging analysis showed a higher ratio of residual alveolar bone, BV/TV, and Tb.N in both Wistar-Kyoto and spontaneously hypertensive rats treated with butoxamine compared with the corresponding control rats. In histological analysis, compared with the Wistar-Kyoto and spontaneously hypertensive rat control groups, the corresponding butoxamine-treated groups showed a lower ratio of attachment level, lower values of osteoclast number and surface.
    Significance: β2-AR blockers maintained the alveolar bone mass and attachment level by suppressing osteoclast activity. Thus, β2-AR blockers may be effective in preventing periodontitis.
    MeSH term(s) Adrenergic beta-2 Receptor Antagonists/pharmacology ; Alveolar Bone Loss/metabolism ; Animals ; Blood Pressure/drug effects ; Bone Density/drug effects ; Bone and Bones/drug effects ; Butoxamine/metabolism ; Butoxamine/pharmacology ; Female ; Hypertension/metabolism ; Male ; Osteoclasts/drug effects ; Periodontitis/drug therapy ; Rats ; Rats, Inbred SHR ; Rats, Inbred WKY ; Receptors, Adrenergic/metabolism ; Receptors, Adrenergic, beta-2/metabolism ; Sympathetic Nervous System/drug effects ; X-Ray Microtomography/methods
    Chemical Substances Adrenergic beta-2 Receptor Antagonists ; Receptors, Adrenergic ; Receptors, Adrenergic, beta-2 ; Butoxamine (0NM31M53PW)
    Language English
    Publishing date 2021-05-09
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 3378-9
    ISSN 1879-0631 ; 0024-3205
    ISSN (online) 1879-0631
    ISSN 0024-3205
    DOI 10.1016/j.lfs.2021.119593
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Attenuation of Bone Formation through a Decrease in Osteoblasts in Mutant Mice Lacking the GM2/GD2 Synthase Gene.

    Sasaki, Eri / Hamamura, Kazunori / Mishima, Yoshitaka / Furukawa, Koichi / Nagao, Mayu / Kato, Hanami / Hamajima, Kosuke / Sato, Takuma / Miyazawa, Ken / Goto, Shigemi / Togari, Akifumi

    International journal of molecular sciences

    2022  Volume 23, Issue 16

    Abstract: The ganglioside GD1a has been reported to promote the differentiation of mesenchymal stem cells to osteoblasts in cell culture systems. However, the involvement of gangliosides, including GD1a, in bone formation in vivo remains unknown; therefore, we ... ...

    Abstract The ganglioside GD1a has been reported to promote the differentiation of mesenchymal stem cells to osteoblasts in cell culture systems. However, the involvement of gangliosides, including GD1a, in bone formation in vivo remains unknown; therefore, we herein investigated their roles in GM2/GD2 synthase-knockout (GM2/GD2S KO) mice without GD1a. The femoral cancellous bone mass was analyzed using three-dimensional micro-computed tomography. A histomorphometric analysis of bone using hematoxylin and eosin (HE) and tartrate-resistant acid phosphatase was performed to examine bone formation and resorption, respectively. Calcein double labeling was also conducted to evaluate bone formation. Although no significant differences were observed in bone mass or resorption between GM2/GD2S KO mice and wild-type (WT) mice, analyses of the parameters of bone formation using HE staining and calcein double labeling revealed less bone formation in GM2/GD2S KO mice than in WT mice. These results suggest that gangliosides play roles in bone formation.
    MeSH term(s) Animals ; Gangliosides ; Mice ; Mice, Knockout ; N-Acetylgalactosaminyltransferases ; Osteoblasts ; Osteogenesis/genetics ; X-Ray Microtomography
    Chemical Substances Gangliosides ; N-Acetylgalactosaminyltransferases (EC 2.4.1.-) ; (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase (EC 2.4.1.92)
    Language English
    Publishing date 2022-08-12
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms23169044
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Store-operated calcium entry induced by activation of Gq-coupled alpha1B adrenergic receptor in human osteoblast.

    Kodama, Daisuke / Togari, Akifumi

    Biochemical and biophysical research communications

    2013  Volume 437, Issue 2, Page(s) 239–244

    Abstract: Recent studies have revealed that the sympathetic nervous system is involved in bone metabolism. We previously reported that noradrenaline (NA) suppressed K(+) currents via Gi/o protein-coupled alpha1B-adrenergic receptor (α1B-AR) in human osteoblast SaM- ...

    Abstract Recent studies have revealed that the sympathetic nervous system is involved in bone metabolism. We previously reported that noradrenaline (NA) suppressed K(+) currents via Gi/o protein-coupled alpha1B-adrenergic receptor (α1B-AR) in human osteoblast SaM-1 cells. Additionally, it has been demonstrated that the intracellular Ca(2+) level ([Ca(2+)]i) was increased by NA via α1B-AR. In this study, we investigated the signal pathway of NA-induced [Ca(2+)]i elevation by using Ca(2+) fluorescence imaging in SaM-1 cells. NA-induced [Ca(2+)]i elevation was suppressed by pretreatment with a PLC inhibitor, U73122. This suggested that the [Ca(2+)]i elevation was mediated by Gq protein-coupled α1B-AR. On the other hand, NA-induced [Ca(2+)]i elevation was completely abolished in Ca(2+)-free solution, which suggested that Ca(2+) influx is the predominant pathway of NA-induced [Ca(2+)]i elevation. Although the inhibition of K(+) channel by NA caused membrane depolarization, the [Ca(2+)]i elevation was not affected by voltage-dependent Ca(2+) channel blockers, nifedipine and mibefradil. Meanwhile, NA-induced [Ca(2+)]i elevation was abolished following activation of store-operated Ca(2+) channel by thapsigargin. Additionally, the [Ca(2+)]i elevation was suppressed by store-operated channel inhibitors, 2-APB, flufenamate, GdCl3 and LaCl3. These results suggest that Ca(2+) influx through store-operated Ca(2+) channels plays a critical role in the signal transduction pathway of Gq protein-coupled α1B-AR in human osteoblasts.
    MeSH term(s) Adult ; Calcium/metabolism ; Cells, Cultured ; GTP-Binding Protein alpha Subunits, Gq-G11/metabolism ; Humans ; Male ; Osteoblasts/cytology ; Osteoblasts/metabolism ; Receptors, Adrenergic, alpha-1/metabolism
    Chemical Substances Receptors, Adrenergic, alpha-1 ; GTP-Binding Protein alpha Subunits, Gq-G11 (EC 3.6.5.1) ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2013-07-26
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 205723-2
    ISSN 1090-2104 ; 0006-291X ; 0006-291X
    ISSN (online) 1090-2104 ; 0006-291X
    ISSN 0006-291X
    DOI 10.1016/j.bbrc.2013.06.047
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Bidirectional communication between sensory neurons and osteoblasts in an in vitro coculture system.

    Kodama, Daisuke / Hirai, Takao / Kondo, Hisataka / Hamamura, Kazunori / Togari, Akifumi

    FEBS letters

    2017  Volume 591, Issue 3, Page(s) 527–539

    Abstract: Recent studies have revealed that the sensory nervous system is involved in bone metabolism. However, the mechanism of communication between neurons and osteoblasts is yet to be elucidated. In this study, we investigated the signaling pathways between ... ...

    Abstract Recent studies have revealed that the sensory nervous system is involved in bone metabolism. However, the mechanism of communication between neurons and osteoblasts is yet to be elucidated. In this study, we investigated the signaling pathways between sensory neurons of the dorsal root ganglion (DRG) and the osteoblast-like MC3T3-E1 cells using an in vitro coculture system. Our findings indicate that signal transduction from DRG-derived neurons to MC3T3-E1 cells is suppressed by antagonists of the AMPA receptor and the NK
    MeSH term(s) Adenosine Triphosphate/pharmacology ; Animals ; Bradykinin/pharmacology ; Calcium/metabolism ; Cell Communication/drug effects ; Cell Line ; Coculture Techniques/methods ; Exocytosis/drug effects ; Ganglia, Spinal/cytology ; Glutamic Acid/metabolism ; Humans ; Mice, Inbred BALB C ; Neurotransmitter Agents/metabolism ; Osteoblasts/cytology ; Osteoblasts/drug effects ; Osteoblasts/metabolism ; Sensory Receptor Cells/cytology ; Sensory Receptor Cells/drug effects ; Sensory Receptor Cells/metabolism ; Signal Transduction/drug effects ; Substance P/metabolism
    Chemical Substances Neurotransmitter Agents ; Substance P (33507-63-0) ; Glutamic Acid (3KX376GY7L) ; Adenosine Triphosphate (8L70Q75FXE) ; Bradykinin (S8TIM42R2W) ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2017-02
    Publishing country England
    Document type Letter
    ZDB-ID 212746-5
    ISSN 1873-3468 ; 0014-5793
    ISSN (online) 1873-3468
    ISSN 0014-5793
    DOI 10.1002/1873-3468.12561
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Effects of a β2-adrenergic receptor blocker on experimental periodontitis in spontaneously hypertensive rats

    Takeguchi, Atsushi / Miyazawa, Ken / Sato, Takuma / Tabuchi, Masako / Muramatsu, Ryujiro / Maeda, Hatsuhiko / Togari, Akifumi / Goto, Shigemi

    Life sciences. 2021 July 15, v. 277

    2021  

    Abstract: Recent studies have reported a relationship between periodontal disease and hypertension, and previous evidence suggests that the sympathetic nervous system plays an important role in the control of bone metabolism. This study sought to evaluate the ... ...

    Abstract Recent studies have reported a relationship between periodontal disease and hypertension, and previous evidence suggests that the sympathetic nervous system plays an important role in the control of bone metabolism. This study sought to evaluate the effect of the beta-2 adrenergic receptor (β2-AR) blocker butoxamine on experimental periodontitis in a rat model.Wistar-Kyoto and spontaneously hypertensive rats (n = 6 per group) were orally administered butoxamine 1 mg/kg/day and experimental periodontitis was induced by applying an orthodontic ligature wire. The rats were sacrificed after 4 weeks and the residual alveolar bone was measured using micro-computed tomography (micro-CT) imaging analysis software for histological analysis.Micro-CT imaging analysis showed a higher ratio of residual alveolar bone, BV/TV, and Tb.N in both Wistar-Kyoto and spontaneously hypertensive rats treated with butoxamine compared with the corresponding control rats. In histological analysis, compared with the Wistar-Kyoto and spontaneously hypertensive rat control groups, the corresponding butoxamine-treated groups showed a lower ratio of attachment level, lower values of osteoclast number and surface.β2-AR blockers maintained the alveolar bone mass and attachment level by suppressing osteoclast activity. Thus, β2-AR blockers may be effective in preventing periodontitis.
    Keywords beta-2 adrenergic receptors ; bone density ; bone metabolism ; computer software ; histology ; hypertension ; micro-computed tomography ; osteoclasts ; periodontitis ; rats ; sympathetic nervous system
    Language English
    Dates of publication 2021-0715
    Publishing place Elsevier Inc.
    Document type Article
    Note NAL-AP-2-clean
    ZDB-ID 3378-9
    ISSN 1879-0631 ; 0024-3205
    ISSN (online) 1879-0631
    ISSN 0024-3205
    DOI 10.1016/j.lfs.2021.119593
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top